APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Traveler's Diarrhea Therapeutics

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

Selected research

Market Structure

Global Traveler's Diarrhea Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174042860319 December 2025185 pages

Choose your research edition.

Industry ResearchTraveler's Diarrhea Therapeutics Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Traveler's Diarrhea Therapeutics Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Traveler's Diarrhea Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Traveler's Diarrhea Therapeutics Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Traveler's Diarrhea Therapeutics Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.

North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.

This report provides an overview of the global Traveler's Diarrhea Therapeutics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Traveler's Diarrhea Therapeutics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Traveler's Diarrhea Therapeutics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Traveler's Diarrhea Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.

Traveler's Diarrhea Therapeutics Segment by Company

Salix Pharmaceuticals

P&G

Johnson & Johnson

Otsuka Pharma

Valneva

Shanghai United Cell

PaxVax

Livzon

Immuron

Traveler's Diarrhea Therapeutics Segment by Type

Immunization

Non-antibiotic Agents

Antibiotics

Anti-Motility Agents

Others

Traveler's Diarrhea Therapeutics Segment by Application

Adult Traveler's Diarrhea

Children Traveler's Diarrhea

Traveler's Diarrhea Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Traveler's Diarrhea Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Traveler's Diarrhea Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Traveler's Diarrhea Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Traveler's Diarrhea Therapeutics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Traveler's Diarrhea Therapeutics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Traveler's Diarrhea Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Traveler's Diarrhea Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Traveler's Diarrhea Therapeutics Industry Trends Table 2. Traveler's Diarrhea Therapeutics Industry Drivers Table 3. Traveler's Diarrhea Therapeutics Industry Opportunities and Challenges Table 4. Traveler's Diarrhea Therapeutics Industry Restraints Table 5. Global Traveler's Diarrhea Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Traveler's Diarrhea Therapeutics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Traveler's Diarrhea Therapeutics Sales Market Share by Manufacturers Table 9. Global Traveler's Diarrhea Therapeutics Average Sales Price (USD/Unit) of Manufacturers (2021-2026) Table 10. Global Traveler's Diarrhea Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Traveler's Diarrhea Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Traveler's Diarrhea Therapeutics Manufacturers, Product Type & Application Table 13. Global Traveler's Diarrhea Therapeutics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Traveler's Diarrhea Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Immunization Table 17. Major Manufacturers of Non-antibiotic Agents Table 18. Major Manufacturers of Antibiotics Table 19. Major Manufacturers of Anti-Motility Agents Table 20. Major Manufacturers of Others Table 21. Global Traveler's Diarrhea Therapeutics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2026) & (K Units) Table 23. Global Traveler's Diarrhea Therapeutics Sales by Type (2027-2032) & (K Units) Table 24. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2021-2026) Table 25. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2027-2032) Table 26. Global Traveler's Diarrhea Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Traveler's Diarrhea Therapeutics Revenue by Type (2021-2026) & (K Units) Table 28. Global Traveler's Diarrhea Therapeutics Revenue by Type (2027-2032) & (K Units) Table 29. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2021-2026) Table 30. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Adult Traveler's Diarrhea Table 32. Major Manufacturers of Children Traveler's Diarrhea Table 33. Global Traveler's Diarrhea Therapeutics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2026) & (K Units) Table 35. Global Traveler's Diarrhea Therapeutics Sales by Application (2027-2032) & (K Units) Table 36. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2021-2026) Table 37. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2027-2032) Table 38. Global Traveler's Diarrhea Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Traveler's Diarrhea Therapeutics Revenue by Application (2021-2026) & (K Units) Table 40. Global Traveler's Diarrhea Therapeutics Revenue by Application (2027-2032) & (K Units) Table 41. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2021-2026) Table 42. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2027-2032) Table 43. Global Traveler's Diarrhea Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Traveler's Diarrhea Therapeutics Sales by Region (2021-2026) & (K Units) Table 45. Global Traveler's Diarrhea Therapeutics Sales Market Share by Region (2021-2026) Table 46. Global Traveler's Diarrhea Therapeutics Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Traveler's Diarrhea Therapeutics Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 50. North America Traveler's Diarrhea Therapeutics Sales by Country (2027-2032) & (K Units) Table 51. Europe Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 53. Europe Traveler's Diarrhea Therapeutics Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Traveler's Diarrhea Therapeutics Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2027-2032) & (K Units) Table 60. Global Traveler's Diarrhea Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Traveler's Diarrhea Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Traveler's Diarrhea Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2021-2026) Table 64. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2027-2032) Table 65. Salix Pharmaceuticals Company Information Table 66. Salix Pharmaceuticals Business Overview Table 67. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio Table 69. Salix Pharmaceuticals Recent Development Table 70. P&G Company Information Table 71. P&G Business Overview Table 72. P&G Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. P&G Traveler's Diarrhea Therapeutics Product Portfolio Table 74. P&G Recent Development Table 75. Johnson & Johnson Company Information Table 76. Johnson & Johnson Business Overview Table 77. Johnson & Johnson Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio Table 79. Johnson & Johnson Recent Development Table 80. Otsuka Pharma Company Information Table 81. Otsuka Pharma Business Overview Table 82. Otsuka Pharma Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio Table 84. Otsuka Pharma Recent Development Table 85. Valneva Company Information Table 86. Valneva Business Overview Table 87. Valneva Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Valneva Traveler's Diarrhea Therapeutics Product Portfolio Table 89. Valneva Recent Development Table 90. Shanghai United Cell Company Information Table 91. Shanghai United Cell Business Overview Table 92. Shanghai United Cell Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio Table 94. Shanghai United Cell Recent Development Table 95. PaxVax Company Information Table 96. PaxVax Business Overview Table 97. PaxVax Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. PaxVax Traveler's Diarrhea Therapeutics Product Portfolio Table 99. PaxVax Recent Development Table 100. Livzon Company Information Table 101. Livzon Business Overview Table 102. Livzon Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Livzon Traveler's Diarrhea Therapeutics Product Portfolio Table 104. Livzon Recent Development Table 105. Immuron Company Information Table 106. Immuron Business Overview Table 107. Immuron Traveler's Diarrhea Therapeutics Sales (K Units), Price (USD/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Immuron Traveler's Diarrhea Therapeutics Product Portfolio Table 109. Immuron Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Traveler's Diarrhea Therapeutics Distributors List Table 113. Traveler's Diarrhea Therapeutics Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Traveler's Diarrhea Therapeutics Product Image Figure 2. Global Traveler's Diarrhea Therapeutics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Traveler's Diarrhea Therapeutics Market Size (2021-2032) & (US$ Million) Figure 4. Global Traveler's Diarrhea Therapeutics Sales (2021-2032) & (K Units) Figure 5. Global Traveler's Diarrhea Therapeutics Average Price (USD/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Traveler's Diarrhea Therapeutics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Immunization Image Figure 9. Non-antibiotic Agents Image Figure 10. Antibiotics Image Figure 11. Anti-Motility Agents Image Figure 12. Others Image Figure 13. Global Traveler's Diarrhea Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Traveler's Diarrhea Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2021-2032) Figure 16. Global Traveler's Diarrhea Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Traveler's Diarrhea Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2021-2032) Figure 19. Adult Traveler's Diarrhea Image Figure 20. Children Traveler's Diarrhea Image Figure 21. Global Traveler's Diarrhea Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Traveler's Diarrhea Therapeutics Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2021-2032) Figure 24. Global Traveler's Diarrhea Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Traveler's Diarrhea Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2021-2032) Figure 27. North America Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2032) Figure 29. U.S. Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2032) Figure 34. Germany Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2032) Figure 41. China Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales Market Share by Country (2021-2032) Figure 49. Brazil Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Traveler's Diarrhea Therapeutics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Traveler's Diarrhea Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Traveler's Diarrhea Therapeutics Revenue (2021-2032) & (US$ Million) Figure 60. North America Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Traveler's Diarrhea Therapeutics Revenue (2021-2032) & (US$ Million) Figure 62. Europe Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Traveler's Diarrhea Therapeutics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Traveler's Diarrhea Therapeutics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Immunization
  • Non-antibiotic Agents
  • Antibiotics
  • Anti-Motility Agents
  • Others
Applications
  • Adult Traveler's Diarrhea
  • Children Traveler's Diarrhea
Companies covered
  • Salix Pharmaceuticals
  • P&G
  • Johnson & Johnson
  • Otsuka Pharma
  • Valneva
  • Shanghai United Cell
  • PaxVax
  • Livzon
  • Immuron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Traveler's Diarrhea Therapeutics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Traveler's Diarrhea Therapeutics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Traveler's Diarrhea Therapeutics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Traveler's Diarrhea Therapeutics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Traveler's Diarrhea Therapeutics Market Dynamics
  1. 2.1 Traveler's Diarrhea Therapeutics Industry Trends
  2. 2.2 Traveler's Diarrhea Therapeutics Industry Drivers
  3. 2.3 Traveler's Diarrhea Therapeutics Industry Opportunities and Challenges
  4. 2.4 Traveler's Diarrhea Therapeutics Industry Restraints
3 Traveler's Diarrhea Therapeutics Market by Manufacturers
  1. 3.1 Global Traveler's Diarrhea Therapeutics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Traveler's Diarrhea Therapeutics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Traveler's Diarrhea Therapeutics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Traveler's Diarrhea Therapeutics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Traveler's Diarrhea Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Traveler's Diarrhea Therapeutics Manufacturers, Product Type & Application
  7. 3.7 Global Traveler's Diarrhea Therapeutics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Traveler's Diarrhea Therapeutics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Traveler's Diarrhea Therapeutics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Traveler's Diarrhea Therapeutics Tier 1, Tier 2, and Tier 3
4 Traveler's Diarrhea Therapeutics Market by Type
  1. 4.1 Traveler's Diarrhea Therapeutics Type Introduction
  2. 4.1.1 Immunization
  3. 4.1.2 Non-antibiotic Agents
  4. 4.1.3 Antibiotics
  5. 4.1.4 Anti-Motility Agents
  6. 4.1.5 Others
  7. 4.2 Global Traveler's Diarrhea Therapeutics Sales by Type
  8. 4.2.1 Global Traveler's Diarrhea Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Traveler's Diarrhea Therapeutics Sales by Type (2021-2032)
  10. 4.2.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2021-2032)
  11. 4.3 Global Traveler's Diarrhea Therapeutics Revenue by Type
  12. 4.3.1 Global Traveler's Diarrhea Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Traveler's Diarrhea Therapeutics Revenue by Type (2021-2032)
  14. 4.3.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Type (2021-2032)
5 Traveler's Diarrhea Therapeutics Market by Application
  1. 5.1 Traveler's Diarrhea Therapeutics Application Introduction
  2. 5.1.1 Adult Traveler's Diarrhea
  3. 5.1.2 Children Traveler's Diarrhea
  4. 5.2 Global Traveler's Diarrhea Therapeutics Sales by Application
  5. 5.2.1 Global Traveler's Diarrhea Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Traveler's Diarrhea Therapeutics Sales by Application (2021-2032)
  7. 5.2.3 Global Traveler's Diarrhea Therapeutics Sales Market Share by Application (2021-2032)
  8. 5.3 Global Traveler's Diarrhea Therapeutics Revenue by Application
  9. 5.3.1 Global Traveler's Diarrhea Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Traveler's Diarrhea Therapeutics Revenue by Application (2021-2032)
  11. 5.3.3 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Application (2021-2032)
6 Global Traveler's Diarrhea Therapeutics Sales by Region
  1. 6.1 Global Traveler's Diarrhea Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Traveler's Diarrhea Therapeutics Sales by Region (2021-2032)
  3. 6.2.1 Global Traveler's Diarrhea Therapeutics Sales by Region (2021-2026)
  4. 6.2.2 Global Traveler's Diarrhea Therapeutics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Traveler's Diarrhea Therapeutics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Traveler's Diarrhea Therapeutics Revenue by Region
  1. 7.1 Global Traveler's Diarrhea Therapeutics Revenue by Region
  2. 7.1.1 Global Traveler's Diarrhea Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Traveler's Diarrhea Therapeutics Revenue by Region (2021-2026)
  4. 7.1.3 Global Traveler's Diarrhea Therapeutics Revenue by Region (2027-2032)
  5. 7.1.4 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Traveler's Diarrhea Therapeutics Revenue (2021-2032)
  8. 7.2.2 North America Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Traveler's Diarrhea Therapeutics Revenue (2021-2032)
  11. 7.3.2 Europe Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Traveler's Diarrhea Therapeutics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Traveler's Diarrhea Therapeutics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Salix Pharmaceuticals
  2. 8.1.1 Salix Pharmaceuticals Company Information
  3. 8.1.2 Salix Pharmaceuticals Business Overview
  4. 8.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolio
  6. 8.1.5 Salix Pharmaceuticals Recent Developments
  7. 8.2 P&G
  8. 8.2.1 P&G Company Information
  9. 8.2.2 P&G Business Overview
  10. 8.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 P&G Traveler's Diarrhea Therapeutics Product Portfolio
  12. 8.2.5 P&G Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Otsuka Pharma
  20. 8.4.1 Otsuka Pharma Company Information
  21. 8.4.2 Otsuka Pharma Business Overview
  22. 8.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolio
  24. 8.4.5 Otsuka Pharma Recent Developments
  25. 8.5 Valneva
  26. 8.5.1 Valneva Company Information
  27. 8.5.2 Valneva Business Overview
  28. 8.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Valneva Traveler's Diarrhea Therapeutics Product Portfolio
  30. 8.5.5 Valneva Recent Developments
  31. 8.6 Shanghai United Cell
  32. 8.6.1 Shanghai United Cell Company Information
  33. 8.6.2 Shanghai United Cell Business Overview
  34. 8.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolio
  36. 8.6.5 Shanghai United Cell Recent Developments
  37. 8.7 PaxVax
  38. 8.7.1 PaxVax Company Information
  39. 8.7.2 PaxVax Business Overview
  40. 8.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 PaxVax Traveler's Diarrhea Therapeutics Product Portfolio
  42. 8.7.5 PaxVax Recent Developments
  43. 8.8 Livzon
  44. 8.8.1 Livzon Company Information
  45. 8.8.2 Livzon Business Overview
  46. 8.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Livzon Traveler's Diarrhea Therapeutics Product Portfolio
  48. 8.8.5 Livzon Recent Developments
  49. 8.9 Immuron
  50. 8.9.1 Immuron Company Information
  51. 8.9.2 Immuron Business Overview
  52. 8.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Immuron Traveler's Diarrhea Therapeutics Product Portfolio
  54. 8.9.5 Immuron Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Traveler's Diarrhea Therapeutics Value Chain Analysis
  2. 9.1.1 Traveler's Diarrhea Therapeutics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Traveler's Diarrhea Therapeutics Production Mode & Process
  6. 9.2 Traveler's Diarrhea Therapeutics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Traveler's Diarrhea Therapeutics Distributors
  9. 9.2.3 Traveler's Diarrhea Therapeutics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst